...
首页> 外文期刊>Journal of Clinical and Diagnostic Research >Capsular Serotyping and Antimicrobial Drug Resistance of Klebsiella pneumoniae Strains Isolated from a Tertiary Care Hospital, Southern India
【24h】

Capsular Serotyping and Antimicrobial Drug Resistance of Klebsiella pneumoniae Strains Isolated from a Tertiary Care Hospital, Southern India

机译:从印度南部一家三级护理医院分离的肺炎克雷伯菌肺炎衣原体的荚膜血清分型和抗药性

获取原文
           

摘要

The rapid spread of Hypervirulent Klebsiella pneumoniae (hvKP) and Multi Drug Resistant (MDR) strains among the clinical isolates of K.pneumoniae is a great deal of concern. The drug resistance and limited treatment options are the major threats. However, the spread of drug resistant strains is through plasmid which may carry virulence determinants such as capsular antigens.Aim: To know the occurrence of hvKP; to study the occurrence of various capsular serotypes such as K1, K2, K3 and K4 among the isolates of K. pneumoniae using Co-agglutination (Co-A) test; to know the occurrence of beta lactamase genes (bla genes) among the K1, K2, K3 and K4 positive serotypes of K. pneumoniae. The study also tried to assess the reproducibility of Co-A test by comparing the result with PCR.Materials and Methods: A prospective study was carried with a total of 60 consecutive, non-duplicate isolates of K. pneumoniae recovered from various clinical specimens obtained from both outpatients and inpatients between April to December 2017. To determine the occurrence of hvKP by string test, the identification of various serotypes was done by Co-A test and PCR. The determination of beta lactamase genes such as blaTEM, blaSHV and blaCTX-M among the capsular serotypes was done by PCR study.Results: Rate of typability by Co-A was found to be 13(21.67%), 0(0%), 32(53.33%), 7(11.67%) for K1, K2, K3 and K4, respectively. Eight (13.33%) of them remained untypable. The rate of typability among the K. pneumoniae K1 serotype by Co-A test and PCR remained somewhat similar.Conclusion: Co-A test is a good method of serotyping and can be used not only for diagnostic purpose but also for epidemiological study.
机译:在肺炎克雷伯菌的临床分离株中,高毒力肺炎克雷伯菌(hvKP)和多药耐药性(MDR)菌株的快速传播引起了广泛关注。耐药性和有限的治疗选择是主要威胁。然而,耐药菌株的传播是通过质粒携带的,该质粒可能携带毒性决定簇,如荚膜抗原。使用共凝集试验(Co-A)研究肺炎克雷伯菌分离株中各种荚膜血清型如K1,K2,K3和K4的发生情况;知道在肺炎克雷伯菌的K1,K2,K3和K4阳性血清型中存在β内酰胺酶基因(bla基因)。该研究还试图通过将结果与PCR进行比较来评估Co-A试验的可重复性。材料与方法:前瞻性研究共进行了60例连续,非重复的肺炎克雷伯菌分离株的分离研究。从2017年4月至2017年12月在门诊和住院患者中获得的临床标本。为通过字符串测试确定hvKP的发生,通过Co-A测试和PCR进行了各种血清型的鉴定。通过PCR研究确定了包膜血清型中β内酰胺酶基因,例如blaTEM,blaSHV和blaCTX-M。结果:发现Co-A的打字率是13(21.67%),0(0 K1,K2,K3和K4分别为%),32(53.33%),7(11.67%)。其中八个(13.33%)仍然无法键入。通过Co-A测试和PCR在肺炎克雷伯菌K1血清型中的可打字率仍然有些相似。结论:Co-A测试是一种良好的血清分型方法,不仅可用于诊断目的,还可用于流行病学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号